accueil  >  revues  >  Encéphalopathies Spongiformes Subaiguës Transmissibles

Introduction aux Encéphalopathies Spongiformes Subaiguës Transmissibles

Auteur : Dr. Joëlle CHABRY - IPMC, CNRS UMR 6097, Sophia Antipolis, France.

Bibliographie :

Adler, V., Zeiler, B., Kryukov, V., Kascsak, R.J., Rubenstein, R. and Grossman, A. (2003) Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. J Mol Biol., 332, 47-57.

Akowitz, A., Sklaviadis, T., Manuelidis, E.E. and Manuelidis, L. (1990) Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations. Microb Pathog., 9, 33-45.

Appel, T.R., Dumpitak, C., Matthiesen, U. and Riesner, D. Prion rods contain an inert polysaccharide scaffold. Biol Chem., 380, 1295-1306.

Baron, G.S., Wehrly, K., Dorward, D.W., Chesebro, B. and Caughey, B. (2002) Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. Embo J, 21, 1031-1040.

Baskakov, I.V., Legname, G., Baldwin, M.A., Prusiner, S.B. and Cohen, F.E. (2002) Pathway complexity of prion protein assembly into amyloid. J Biol Chem., 277, 21140-21148.

Basler, K., Oesch, B., Scott, M., Westaway, D., Walchli, M., Groth, D.F., McKinley, M.P., Prusiner, S.B. and Weissmann, C. (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell, 46, 417-428.

Bernoulli, C., Siegfried, J., Baumgartner, G., Regli, F., Rabinowicz, T., Gajdusek, D.C. and Gibbs, C.J. (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet., 1, 478-479.

Bessen, R.A., Kocisko, D.A., Raymond, G.J., Nandan, S., Lansbury, P.T. and Caughey, B. (1995) Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature, 375, 698-700.

Bessen, R.A. and Marsh, R.F. (1992a) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol., 66, 2096-2101.

Bessen, R.A. and Marsh, R.F. (1992b) Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol., 73, 329-334.

Bessen, R.A. and Marsh, R.F. (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol., 68, 7859-7868.

Bockman, J.M., Prusiner, S.B., Tateishi, J. and Kingsbury, D.T. (1987) Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes. Ann Neurol., 21, 589-595.

Bolton, D.C., McKinley, M.P. and Prusiner, S.B. (1982) Identification of a protein that purifies with the scrapie prion. Science, 218, 1309-1311.

Bosque, P.J. and Prusiner, S. (2000) Cultured cell sublines highly susceptible to prion infection. J Virol, 74, 4377-4386.

Brandner, S., Isenmann, S., Raeber, A., J., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., C., Weissmann. and Aguzzi, A. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature, 379, 339-343.

Brown, D.R., Qin, K., Herms, J.W., Madlung, A., Manson, J., Strome, R., Fraser, P.E., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W., Giese, A., Westaway, D. and Kretzschmar, H. (1997a) The cellular prion protein binds copper in vivo. Nature, 390, 684-687.

Brown, D.R., Schmidt, B. and Kretzschmar, H.A. (1996a) A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia, 18, 59-67.

Brown, D.R., Schmidt, B. and Kretzschmar, H.A. (1996b) Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature, 380, 345-347.

Brown, D.R., Schmidt, B. and Kretzschmar, H.A. (1997b) Effects of oxidative stress on prion protein expression in PC12 cells. Int J Dev Neurosci, 15, 961-972.

Brown, D.R., Wong, B.S., Hafiz, F.B., Clive, C., Haswell, S.J. and Jones, I.M. (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem J, 344, 1-5.

Brown, P., Rau, E.H., Johnson, B.K., Bacote, A.E., Gibbs, C.J. and Gajdusek, D.C. (2000) New studies on the heat resistance of hamster-adapted scrapie agent: threshold survival after ashing at 600 degrees C suggests an inorganic template of replication. Proc Natl Acad Sci U S A., 97, 3418-3421.

Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.A., Autenried, P., Aguet, M. and Weissmann, C. (1993) Mice devoid of PrP are resistant to scrapie. Cell, 73, 1339-1347.

Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S.J., Prusiner, S.B., Aguet, M. and Weissmann, C. (1992) Normal development and behaviour of mice lacking the neuronal cell surface PrP protein. Nature, 356, 577-582.

Bueler, H., Raeber, A., Sailer, A., Fischer, M., Aguzzi, A. and Weissmann, C. (1994) High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol Med., 1, 19-30.

Cashman, N.R., Loertscher, R., Nalbantoglu, J., Shaw, I., Kascsak, R.J., Bolton, D.C. and Bendheim, P.E. (1990) Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell, 61, 185-192.

Caughey, B. (2000) Transmissible spongiform encephalopathies, amyloidoses and yeast prions: common threads? Nat Med., 6, 751-754.

Caughey, B. and Race, R.E. (1992) Potent inhibition of scrapie-associated PrP accumulation by congo red. J Neurochem, 59, 768-771.

Caughey, B. and Raymond, G.J. (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem, 266, 18217-18223.

Caughey, B. and Raymond, G.J. (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol, 67, 643-650.

Caughey, B., Raymond, G.J. and Bessen, R.A. (1998a) Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem, 273, 32230-32235.

Caughey, B., Raymond, G.J., Ernst, D. and Race, R.E. (1991a) N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol, 65, 6597-6603.

Caughey, B.W., Dong, A., Bhat, K.S., Ernst, D., Hayes, S.F. and Caughey, W.S. (1991b) Secondary structure analysis of the scrapie-associated protein PrP 27- 30 in water by infrared spectroscopy. Biochemistry, 30, 7672-7680.

Caughey, W.S., Raymond, L.D., Horiuchi, M. and Caughey, B. (1998b) Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc Natl Acad Sci USA, 95, 12117-12122.

Chandler, R.L. (1961) Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet, 1378-1379.

Chapman, J., Ben-Israel, J., Goldhammer, Y. and Korczyn, A.D. (1994) The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology, 44, 1683-1686.

Chapman, J., Brown, P., Goldfarb, L.G., Arlazoroff, A., Gajdusek, D.C. and Korczyn, A.D. (1993) Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J. Neurol. Neurosurg. Psychiatry, 56, 1109-1112.

Chen, S.G., Teplow, D.B., Parchi, P., Teller, J.K., Gambetti, P. and Autilio-Gambetti, L. (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270, 19173-19180.

Chesebro, B. (1998) BSE and prions: uncertainties about the agent. Science, 279, 42-43.

Chesebro, B., Race, R., Wehrly, K., Nishio, J., Bloom, M., Lechner, D., Bergstrom, S., Robbins, K., Mayer, L., Keith, J.M., Garon, C. and Haase, A. (1985) Identification of scrapie prion protein-specific mRNA in scrapie infected and uninfected brain. Nature, 315, 331-333.

Chiarini, L.B., Freitas, A.O., Zanata, S.M., Brentani, R.R., Vilma R., Martins, V.R. and Rafael Linden, R. (2002) Cellular prion protein transduces neuroprotective signals. Embo J., 21, 3317-3326.

Chiesa, R. and Harris, D.A. (2001) Prion diseases: what is the neurotoxic molecule? Neurobiol Dis., 8, 743-763.

Collinge, G., Whittington, M.A., Sidle, K.C.L., Smith, C.J., Palmer, M.S., Clarke, A.R. and Jefferys, J.G.R. (1994) Prion protein is necessary for normal synaptic function. Nature, 370.

Collinge, J., Sidle, K.C., Meads, J., Ironside, J.W. and Hill, A.F. (1996) Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature, 383, 685-690.

Collins, S.J., Lewis, V., Brazier, M.W., Hill, A.F., Fletcher, A. and Masters, C.L. (2002) Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neurol., 52, 503-506.

Cuillé, J. and Chelle, P.L. (1938) La tremblante du mouton est bien inoculable. CR Acad Sci, 206, 78-79.

DebBurman, S.K., Raymond, G.J., Caughey, B. and Lindquist, S. (1997) Chaperone-supervised conversion of prion protein to its protease- resistant form. Proc Natl Acad Sci USA, 94, 13938-13943.

Deleault, N.R., Lucassen, R.W. and Supattapone, S. (2003) RNA molecules stimulate prion protein conversion. Nature, 425, 673-674.

Demaimay, R., Adjou, K.T., Beringue, V., Demart, S., Lasmezas, C.I., Deslys, J.P., Seman, M. and Dormont, D. (1997) Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. J Virol, 71, 9685-9689.

Demaimay, R., Chesebro, B. and Caughey, B. (2000) Inhibition of formation of protease-resistant prion protein by Trypan Blue, Sirius Red and other Congo Red analogs. Arch Virol Suppl., 16, 277-283.

Dickinson, A.G. and Taylor, D.M. (1978) Resistance of scrapie to decontamination. New Eng J Med, 299, 1413-1414.

Doh-Ura, K., Iwaki, T. and Caughey, B. (2000) Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol., 74, 4894-4897.

Donne, D.G., Viles, J.H., Groth, D., Mehlhorn, I., James, T.L., Cohen, F.E., Prusiner, S.B., Wright, P.E. and Dyson, H.J. (1997) Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci USA., 94, 13452-13457.

Drisaldi, B., Stewart, R.S., Adles, C., Stewart, L.R., Quaglio, E., Biasini, E., Fioriti, L., Chiesa, R. and Harris, D.A. (2003) Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem, 278, 21732-21743.

Enari, M., Flechsig, E. and Weissmann, C. (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci USA, 98, 9295-9299.

Ford, M.J., Burton, L.J., Li, H., Graham, C.H., Frobert, Y., Grassi, J., Hall, S.M. and Morris, R.J. A marked disparity between the expression of prion protein and its message by neurones of the CNS. Neuroscience, 111, 533-551.

Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O. and Tagliavini, F. (1993) Neurotoxicity of a prion protein fragment. Nature, 362, 543-546.

Fournier, J.-G., Escaig-Haye, F., Billette de Villemeur, T. and Robain, O. (1995) Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. C R Acad Sci III., 318, 339-344.

Fraser, H. and Dickinson, A.G. (1985) Targeting of scrapie lesions and spread of agent via the retino-tectal projection. Brain Res, 346, 32-41.

Gabizon, R., Telling, G., Meiner, Z., Halimi, M., Kahana, I. and Prusiner, S.B. (1996) Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med, 2, 59-64.

Gabriel, J.-M., Oesch, B., Kretzschmar, H., Scott, M. and Prusiner, S.B. (1992) Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci USA, 89, 9097-9101.

Gabus, C., Derrington, E., Leblanc, P., Chnaiderman, J., Dormont, D., Swietnicki, W., Morillas, M., Surewicz, W.K., Marc, D., Nandi, P. and Darlix, J. (2001) The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J Biol Chem, 276, 19301-19309.

Gajdusek, D.C., Gibbs, C.J. and Alpers, M. (1966) Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature, 209, 794-796.

Gajdusek, D.C., Gibbs, C.J. and Alpers, M. (1967) Transmission and passage of experimenal "kuru" to chimpanzees. Science., 155, 212-214.

Gajdusek, D.C., Gibbs, C.J., Asher, D.M., Brown, P., Diwan, A., Hoffman, P., Nemo, G., Rohwer, R. and White, L. (1977) Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med., 297, 1253-1258.

Gibbs, C.J., Gajdusek, D.C., Asher, D.M., Alpers, M.P., Beck, E., Daniel, P.M. and Matthews, W.B. (1968) Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science, 161, 388-389.

Glatzel, M., Abela, E., Maissen, M. and Aguzzi, A. (2003) Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med., 349, 1812-1820.

Goldfarb, L.G., Brown, P., Mitrova, E., Cervenakova, L., Goldin, L., Korczyn, A.D., Chapman, J., Galvez, S., Cartier, L. and Rubenstein, R. (1991) Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur J Epidemiol, 7, 477-486.

Gorodinsky, A. and Harris, D.A. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J Cell Biol., 129, 619-627.

Griffith, J.S. (1967) Self-replication and scrapie. Nature, 215, 1043-1044.

Hadlow, W.J. (1959) Scrapie and kuru. Lancet, 2, 289-290.

Hegde, R.S., Mastrianni, J.A., Scott, M.R., DeFea, K.A., Tremblay, P., Torchia, M., DeArmond, S.J., Prusiner, S.B. and Lingappa, V.R. (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science, 279, 827-834.

Hegde, R.S., Tremblay, P., Groth, D., DeArmond, S.J., Prusiner, S.B. and Lingappa, V.R. (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature, 402, 822-826.

Hetz, C., Russelakis-Carneiro, M., Maundrell, K., Castilla, J. and Soto, C. (2003) Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. Embo J, 22, 5435-5445.

Hill, A.F., Desbruslais, M., Joiner, S., Sidle, K.C., Gowland, I., Collinge, J., Doey, L.J. and Lantos, P. (1997) The same prion strain causes vCJD and BSE. Nature, 389, 448-450.

Hill, A.F., Joiner, S., Linehan, J., Desbruslais, M., Lantos, P.L. and Collinge, J. (2000) Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA., 97, 10248-10253.

Hilton, D.A., Fathers, E., Edwards, P., Ironside, J.W. and Zajicek, J. (1998) Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet, 352, 703-704.

Holscher, C., Delius, H. and Burkle, A. (1998) Overexpression of nonconvertible PrPc delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation. J Virol, 72, 1153-1159.

Hope, J., Shearman, M.S., Baxter, H.C., Chong, A., Kelly, S.M. and Price, a.N.C. (1996) Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A? 25-35. Neurodegeneration, 5, 1-11.

Horiuchi, M., Chabry, J. and Caughey, B. (1999) Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. Embo J, 18, 3193-3203.

Hughes, P.M., Botham, M.S., Frentzel, S., Mir, A. and Perry, V.H. (2002) Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia, 37, 314-317.

Jackson, G.S., Hosszu, L.L., Power, A., Hill, A.F., Kenney, J., Saibil, H., Craven, C.J., Waltho, J.P., Clarke, A.R. and Collinge, J. (1999) Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science, 283, 1935-1937.

Jackson, G.S., Murray, I., Hosszu, L.L., Gibbs, N., Waltho, J.P., Clarke, A.R. and Collinge, J. (2001) Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci USA, 98, 8531-8535.

Kaneko, K., Ball, H.L., Wille, H., Zhang, H., Groth, D., Torchia, M., Tremblay, P., Safar, J., Prusiner, S.B., DeArmond, S.J., Baldwin, M.A. and Cohen, F.E. (2000) A synthetic peptide initiates Gerstmann-Straussler-Scheinker (GSS) disease in transgenic mice. J Mol Biol., 295, 997-1007.

Kaneko, K., Peretz, D., Pan, K.-M., Blochberger, T., C., Wille, H., Gabizon, R., Griffith, O., H., Cohen, F., E., Baldwin, M., A. and Stanley, S., B. (1995) Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc. Natl. Acad. Sci. USA, 92, 11160-11164.

Klein, T.R., Kirsch, D., Kaufmann, R. and Riesner, D. (1998) Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biol Chem., 379, 655-666.

Klohn, P.C., Stoltze, L., Flechsig, E., Enari, M. and Weissmann, C. (2003) A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci USA., 100, 11666-11671.

Kocisko, D.A., Come, J.H., Priola, S.A., Chesebro, B., Raymond, G.J., Lansbury, P.T. and Caughey, B. (1994) Cell-free formation of protease-resistant prion protein. Nature, 370, 471-474.

Kurschner, C. and Morgan, J.I. (1995) The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res Mol Brain Res, 30, 165-168.

Kuwahara, C., Takeuchi, A.M., Nishimura, T., Haraguchi, K., Kubosaki, A., Matsumoto, Y., Saeki, K., Yokoyama, T., Itohara, S. and Onodera, T. (1999) Prions prevent neuronal cell-line death. Nature, 400, 225-226.

Lasmezas, C.I., Deslys, J., Robain, O., Jaegly, A., Beringue, V., Peyrin, J., Fournier, J., Hauw, J., Rossier, J. and Dormont, D. (1997) Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science., 275, 402-405.

Leblanc, P., Baas, D. and Darlix, J. (2004) Analysis of the Interactions Between HIV-1 and the Cellular Prion Protein in a Human Cell Line. J Mol Biol., 337, 1035-1051.

Lehmann, S., Milhavet, O. and Mange, A. (1999) Trafficking of the cellular isoform of the prion protein. Biomed Pharmacother., 53, 39-46.

Luhr, K.M., Nordstrom, E.K., Low, P., Ljunggren, H.G., Taraboulos, A. and Kristensson, K. (2004) Scrapie Protein Degradation by Cysteine Proteases in CD11c(+) Dendritic Cells and GT1-1 Neuronal Cells. J Virol., 78, 4776-4782.

Ma, J. and Lindquist, S. (2002) Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science, 298, 1785-1788.

Ma, J., Wollmann, R. and Lindquist, S. (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science, 298, 1781-1785.

Mallucci, G.R., Dickinson, A., Linehan, J., Klohn, P.C., Brandner, S. and Collinge, J. (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science, 302, 871-874.

Mallucci, G.R., Ratte, S., Asante, E.A., Linehan, J., Gowland, I., Jefferys, J.G. and Collinge, J. (2002) Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J., 21, 202-210.

Mange, A., Milhavet, O., McMahon, H.E., Casanova, D. and Lehmann, S. (2000a) Effect of amphotericin B on wild-type and mutated prion proteins in cultured cells: putative mechanism of action in transmissible spongiform encephalopathies. J Neurochem, 74, 754-762.

Mange, A., Nishida, N., Milhavet, O., McMahon, H.E., Casanova, D. and Lehmann, S. (2000b) Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol, 74, 3135-3140.

Manson, J., West, J.D., Thomson, V., McBride, P.A., Kaufman, M.H. and Hope, J. (1992) The prion protein gene: a role in mouse embryogenesis? Development., 115, 117-122.

Marella, M., Lehmann, S., Grassi, J. and Chabry, J. (2002) Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J Biol Chem, 277, 25457-25464.

Martins, V.R., Graner, E., Garcia-Abreu, J., de Souza, S.J., Mercadante, A.F., Veiga, S.S., Zanata, S.M., Neto, V.M. and Brentani, R.R. (1997) Complementary hydropathy identifies a cellular prion protein receptor. Nat Med, 3, 1376-1382.

Mastrangelo, P., Serpell, L., Dafforn, T., Lesk, A., Fraser, P. and Westaway, D. (2002) A cluster of familial Creutzfeldt-Jakob disease mutations recapitulate conserved residues in Doppel: a case of molecular mimicry? FEBS Lett, 532, 21-26.

McKinley, M.P., Bolton, D.C. and Prusiner, S.B. (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell, 35, 57-62.

Moscardini, M., Pistello, M., Bendinelli, M., Ficheux, D., Miller, J.T., Gabus, C., Le Grice, S.F., Surewicz, W.K. and Darlix, J. (2002) Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. J Mol Biol, 318, 149-159.

Müller, W.E.G., Ushijima, H., Schröder, H.C., Forrest, J.M.S., Schatton, W.F.H., Rytik, P.G. and Heffner-Lauc, M. (1993) Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur. J Pharmacol, 246, 261-267.

Nandi, P.K., Leclerc, E., Nicole, J.-C. and Takahashi, M. (2002) DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid. J Mol Biol, 6322, 153-161.

Nishida, N., Harris, D.A., Vilette, D., Laude, H., Frobert, Y., Grassi, J., Casanova, D., Milhavet, O. and Lehmann, S. (2000) Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol, 74, 320-325.

Oesch, B., Westaway, D., Walchli, M., Mckinley, M.P., Kent, S.B., Aebersold, R., Barry, R.A., Tempst, P., Teplow, D.B., Hood, L.E., Prusiner, S.B. and Weissmann, C. (1985) A cellular gene encodes scrapie PrP 27-30 protein. Cell, 40, 735-746.

Parizek, P., Roeckl, C., Weber, J., Flechsig, E., Aguzzi, A. and Raeber, A.J. (2001) Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells. J Biol Chem, 276, 44627-44632.

Parkin, E.T., Watt, N.T., Turner, A.J. and Hooper, N.M. (2004) Dual mechanisms for shedding of the cellular prion protein. J Biol Chem, 279, 11170-11178.

Pauly, P.C. and Harris, D.A. (1998) Copper stimulates endocytosis of the prion protein. J Biol Chem, 273, 33107-33110.

Pillot, T., Lins, L., Goethals, M., Vanloo, B., Baert, J., Vandekerckhove, J., Rosseneu, M. and Brasseur, R. (1997) The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion. J Mol Biol, 274, 381-393.

Priola, S.A., Raines, A. and Caughey, W.S. (2000) Porphyrin and phthalocyanine antiscrapie compounds. Science, 287, 1503-1506.

Prusiner, S.B. (1982) Novel proteinaceous infectious particles cause scrapie. Science, 216, 136-144.

Prusiner, S.B., Mckinley, M.P., Groth, D.F., Bowman, K.A., Mock, N.I., Cochran, S.P. and Masiarz, F.R. (1981) Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci USA, 78, 6675-6679.

Race, R. and Chesebro, B. (1998) Scrapie infectivity found in resistant species. Nature, 392, 770.

Race, R.E., Fadness, L.H. and Chesebro, B. (1987) Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol., 68, 1391-1399.

Raeber, A.J., Brandner, S., Klein, M.A., Benninger, Y., Musahl, C., Frigg, R., Roeckl, C., Fischer, M.B., Weissmann, C. and Aguzzi, A. (1998) Transgenic and knockout mice in research on prion diseases. Brain Pathol, 8, 715-733.

Richardson, E.P. and Masters, C.L. (1995) The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system. Brain Pathol., 5, 33-41.

Rieger, R., Edenhofer, F., Lasmezas, C.I. and Weiss, S. (1997) The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat Med, 3, 1383-1388.

Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R. and Wuthrich, K. (1996) NMR structure of the mouse prion protein domain PrP(121-321). Nature, 382, 180-182.

Riesner, D., Kellings, K., Post, K., Wille, H., Serban, H., Groth, D., Baldwin, M.A. and Prusiner, S.B. (1996) Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity. J Virol., 70, 1714-1722.

Rohwer, R.G. (1984) Scrapie infectious agent is virus-like in size and susceptibility to inactivation. Nature, 308, 658-661.

Roucou, X., Guo, Q., Zhang, Y., Goodyer, C.G. and LeBlanc, A.C. (2003) Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J Biol Chem, 278, 40877-40881.

Schmitt-Ulms, G., Legname, G., Baldwin, M.A., Ball, H.L., Bradon, N., Bosque, P.J., Crossin, K.L., Edelman, G.M., DeArmond, S.J., Cohen, F.E. and Prusiner, S.B. (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol, 314, 1209-1225.

Schreuder, B.E., van Keulen, L.J., Vromans, M.E., Langeveld, J. and Smits, M.A. (1996) Preclinical test for prion diseases. Nature, 381, 563.

Scott, M.R.D., Foster, D., Mirenda, C., Serban, D., Coufal, F., Walchii, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S.J., Westaway, D. and Prusiner, S.B. (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell, 59, 847-857.

Selvaginni, C., De Gioia, L., Cantù, L., Ghibaudi, E., Diomede, L., Passerini, F., Forloni, G., Bugiani, O., Tagliavini, F. and Salmona, M. (1993) Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. BBRC, 194, 1380-1386.

Shmerling, D., Hegyi, I., Fischer, M., Blattler, T., Brandner, S., Gotz, J., Rulicke, T., Flechsig, E., Cozzio, A., von Mering, C., Hangartner, C., Aguzzi, A. and Weissmann, C. (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell, 93, 203-214.

Shyng, S.L., Huber, M.T. and Harris, D.A. (1993) A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem, 268, 15922-15928.

Stewart, R.S. and Harris, D.A. (2001) Most pathogenic mutations do not alter the membrane topology of the prion protein. J Biol Chem., 276, 2212-2220.

Telling, G.C., Parchi, P., DeArmond, S.J., Cortelli, P., Montagna, P., Gabizon, R., Mastrianni, J., Lugaresi, E., Gambetti, P. and Prusiner, S. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science, 274, 2079-2082.

Tobler, I., Gaus, S.E., Deboer, T., Achermann, P., Fischer, M., Rulicke, T., Moser, M., Oesch, B., McBride, P.A. and Manson, J.C. (1996) Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature, 380, 639-642.

Vey, M., Pilkuhn, S., Wille, H., Nixon, R., DeArmond, S.J., Smart, E.J., Anderson, R.G., Taraboulos, A. and Prusiner, S.B. (1996) Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A, 93, 14945-14949.

Vilette, D., Andreoletti, O., Archer, F., Madelaine, M.F., Vilotte, J.L., Lehmann, S. and Laude, H. (2001) Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci U S A, 98, 4055-4059.

Vincent, B., Paitel, E., Saftig, P., Frobert, Y., Hartmann, D., De Strooper, B., Grassi, J., Lopez-Perez, E. and Checler, F. (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem, 276, 37743-37746.

Waggoner, D.J., Drisaldi, B., Bartnikas, T.B., Casareno, R.L., Prohaska, J.R., Gitlin, J.D. and Harris, D.A. (2000) Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J Biol Chem, 275, 7455-7458.

Weiss, S., Proske, D., Neumann, M., Groschup, M.H., Kretzschmar, H.A., Famulok, M. and Winnacker, E.L. (1997) RNA aptamers specifically interact with the prion protein PrP. J Virol., 71, 8790-8797.

Weissmann, C. (1991a) Spongiform encephalopathies. The prion's progress. Nature, 349, 569-571.

Weissmann, C. (1991b) A 'unified theory' of prion propagation. Nature, 352, 679-683.

Weissmann, C. (1999) Molecular genetics of transmissible spongiform encephalopathies. J Biol Chem., 274, 3-6.

Wong, C., Xiong, L.W., Horiuchi, M., Raymond, L.D., Wehrly, K., Chesebro, B. and Caughey, B. (2001) Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. Embo J., 20, 377-386.

Zanusso, G., Ferrari, S., Cardone, F., Zampieri, P., Gelati, M., Fiorini, M., Farinazzo, A., Gardiman, M., Cavallaro, T., Bentivoglio, M., Righetti, P., Pocchiari, M., Rizzuto, N. and Monaco, S. (2003) Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N Engl J Med, 348, 711-719.

page précédente - Introduction aux Encéphalopathies Spongiformes Subaiguës Transmissibles - page suivante
haut de page

Cours de biologie  |  Articles de revue  |  Études  |  Offres d'emplois  |  Pense-bête  |  Sélection de livres  |  Nouveautés livres  |  Liens  |  Forum

© - Tous droits réservés.